Unknown

Dataset Information

0

Novel SLC25A32 mutation in a patient with a severe neuromuscular phenotype.

ABSTRACT: In a 51-year-old patient of consanguineous parents with a severe neuromuscular phenotype of early-onset ataxia, myoclonia, dysarthria, muscle weakness and exercise intolerance, exome sequencing revealed a novel homozygous variant (c.-264_31delinsCTCACAAATGCTCA) in the mitochondrial FAD-transporter gene SLC25A32. Flavin adenine dinucleotide (FAD) is an essential co-factor for many mitochondrial enzymes and impaired mitochondrial FAD-transport was supported by a reduced oxidative phosphorylation complex II activity in the patient's muscle, decreased ATP production in fibroblasts, and a deficiency of mitochondrial FAD-dependent enzymes. Clinically, the patient showed improvement upon riboflavin treatment, which is a precursor of FAD. Our results confirm the recently reported case of SLC25A32 as a cause of riboflavin-responsive disease. Our patient showed a more severe clinical phenotype compared with the reported patient, corresponding with the (most likely) complete absence of the SLC25A32-encoding MFT (Mitochondrial Folate Transporter) protein.

SUBMITTER: Hellebrekers DMEI 

PROVIDER: S-EPMC5520074 | biostudies-literature | 2017 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

In a 51-year-old patient of consanguineous parents with a severe neuromuscular phenotype of early-onset ataxia, myoclonia, dysarthria, muscle weakness and exercise intolerance, exome sequencing revealed a novel homozygous variant (c.-264_31delinsCTCACAAATGCTCA) in the mitochondrial FAD-transporter gene SLC25A32. Flavin adenine dinucleotide (FAD) is an essential co-factor for many mitochondrial enzymes and impaired mitochondrial FAD-transport was supported by a reduced oxidative phosphorylation c  ...[more]

Similar Datasets

Unknown Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia.
| S-EPMC2819827 | biostudies-literature
Unknown A Novel Homozygous Truncating Mutation in <i>LAMB2</i> Gene in a Chinese Uyghur Patient With Severe Phenotype Pierson Syndrome.
| S-EPMC6369156 | biostudies-literature
Unknown A Novel GNAS Mutation in a Patient with Ia Pseudohypoparathyroidism (iPPSD2) Phenotype.
| S-EPMC9956201 | biostudies-literature
Unknown Clinical phenotype of a Chinese patient with RIPK1 deficiency due to novel mutation.
| S-EPMC7063410 | biostudies-literature
Unknown A novel dominant mutation in CRYAB gene leading to a severe phenotype with childhood onset.
| S-EPMC7434720 | biostudies-literature
Unknown Novel homozygous mutation in a colombian patient with persistent mullerian duct syndrome: expanded phenotype.
| S-EPMC6844334 | biostudies-literature
Unknown Novel mutation in the NHLRC1 gene in a Malian family with a severe phenotype of Lafora disease.
| S-EPMC2758214 | biostudies-literature
Unknown A novel <i>ABHD5</i> mutation in two Chanarin Dorfman siblings with severe and heterogeneous clinical phenotype.
| S-EPMC10308162 | biostudies-literature
Unknown A novel ELP1 mutation impairs the function of the Elongator complex and causes a severe neurodevelopmental phenotype.
| S-EPMC10290953 | biostudies-literature
Unknown TRMA syndrome with a severe phenotype, cerebral infarction, and novel compound heterozygous SLC19A2 mutation: a case report.
| S-EPMC6625038 | biostudies-literature